Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/NEUROCRINE-BIOSCIENCES-IN-10163/news/Neurocrine-Biosciences-starts-Phase-one-first-in-human-clinical-study-of-NBI-1117567-46676612/?utm_source=whatsapp&utm_medium=social&utm_campaign=share